Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 851 - 875 of 1334 in total
Experimental
Illicit
Experimental
Brensocatib is under investigation in clinical trial NCT03218917 (Assessment of INS1007 in Subjects With Non-cystic Fibrosis Bronchiectasis).
Investigational
Carphenazine is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.
Withdrawn
Lurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer).
Investigational
Thioproperazine is a potent neuroleptic with antipsychotic properties. Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects. It is virtually without antiserotonin and hypotensive action and has no antihistaminic property. It is used for the treatment of all types of acute and...
Experimental
Experimental
Marizomib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Malignant Glioma, among others.
Investigational
Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
Investigational
Fenoverine has been used in trials studying the treatment of Irritable Bowel Syndrome.
Investigational
Experimental
Pentetrazol, also known as pentylenetetrazole, is a gamma-aminobutyric acid type A (GABAA) receptor antagonist that was approved by the FDA until 1982.
Experimental
Withdrawn
PCO-371 is under investigation in clinical trial NCT02475616 (A Single Ascending Dose Study of PCO371 in Healthy Volunteers).
Investigational
Experimental
Matched Iupac: … 5-ethyl-5-[(2E)-pent-2-en-2-yl]-1,3-diazinane-2,4,6-trione …
Ammonium molybdate is a source of molybdenum that exists in several hydrate forms. It is intravenously administered as an additive to solutions for Total Parenteral Nutrition (TPN). Molybdenum is an essential element that is present in enzymes including xanthine oxidase, sulfite oxidase, and aldehyde oxidase.
Experimental
Pentanal is a solid. This compound belongs to the polyamines. These are compounds containing more than one amine group. This drug targets the protein cAMP-dependent protein kinase catalytic subunit alpha.
Experimental
Matched Description: … This drug targets the protein cAMP-dependent protein kinase catalytic subunit alpha. …
PD-98059 is an inhibitor of MAP-kinase kinase activation.
Investigational
Matched Description: … PD-98059 is an inhibitor of MAP-kinase kinase activation.[A253072] …
Matched Categories: … Protein Kinase Inhibitors …
Experimental
A natural product found in Cannabis sativa and Helichrysum species.
Experimental
Sulbutiamine is a synthetic derivative of thiamine (vitamin B1) under the market name Arcalion that is composed of two modified thiamine molecules to form a dimer. It is highly lipophilic, allowing it to cross the blood-brain barrier more easily than other thiamine derivatives. Although its clinical efficacy is not yet...
Experimental
Matched Iupac: … -2-en-3-yl]disulfanyl}pent-3-en-1-yl 2-methylpropanoate ... formamido}-3-{[(2E)-2-{N-[(4-amino-2-methylpyrimidin-5-yl)methyl]formamido}-5-[(2-methylpropanoyl)oxy]pent
AKI-001 is an aurora kinase inhibitor.
Experimental
Matched Description: … AKI-001 is an aurora kinase inhibitor. …
Matched Categories: … Protein Kinase Inhibitors …
Displaying drugs 851 - 875 of 1334 in total